Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.

Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.

<h4>Introduction</h4>Interim PET (iPET) assessment is important for response adaptation in Hodgkin lymphoma (HL). The current standard for iPET assessment is the Deauville score (DS). The aim of our study was to evaluate the causes of interobserver variability in assigning the DS for iPE...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Thomas W Georgi, Lars Kurch, Dirk Hasenclever, Victoria S Warbey, Lucy Pike, John Radford, Osama Sabri, Regine Kluge, Sally F Barrington
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Public Library of Science (PLoS) 2023-01-01
Reeks:	PLoS ONE
Online toegang:	https://doi.org/10.1371/journal.pone.0283694

Gelijkaardige items

Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial.
door: Thomas W Georgi, et al.
Gepubliceerd in: (2020-01-01)

Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma
door: Lars Kurch, et al.
Gepubliceerd in: (2021-09-01)

Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
door: Regine Kluge, et al.
Gepubliceerd in: (2016-01-01)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
door: M. André, et al.
Gepubliceerd in: (2011-01-01)

Automatic classification of lymphoma lesions in FDG-PET–Differentiation between tumor and non-tumor uptake
door: Thomas W Georgi, et al.
Gepubliceerd in: (2022-01-01)

Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake.
door: Thomas W Georgi, et al.
Gepubliceerd in: (2022-01-01)

End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET
door: Karan L. Chohan, et al.
Gepubliceerd in: (2022-12-01)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
door: Akram Al-Ibraheem, et al.
Gepubliceerd in: (2022-10-01)

Interim PET for prognosis in adults with Hodgkin lymphoma: A prognostic factor exemplar review
door: Skoetz, N, et al.
Gepubliceerd in: (2017)

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
door: Diego Villa, et al.
Gepubliceerd in: (2018-12-01)

Prevention of activated brown adipose tissue on 18F-FDG-PET scans of young lymphoma patients: results of an ancillary study within the EuroNet-PHL-C2 trial
door: C. Pötzsch, et al.
Gepubliceerd in: (2023-12-01)

Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim Assessment
door: Elizabeth Katherine Anna Triumbari, et al.
Gepubliceerd in: (2022-09-01)

Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation
door: L. Kurch, et al.
Gepubliceerd in: (2021-07-01)

Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease
door: Tseng Diane, et al.
Gepubliceerd in: (2012-01-01)

Hodgkin lymphoma: hypodense lesions in mediastinal masses
door: Adrian Damek, et al.
Gepubliceerd in: (2024-06-01)

Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies
door: Aldin, A, et al.
Gepubliceerd in: (2019)

Interim PET‐results for prognosis in adults with Hodgkin lymphoma: A systematic review and meta‐analysis of prognostic factor studies
door: Aldin, A, et al.
Gepubliceerd in: (2020)

P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
door: Chiara Rusconi, et al.
Gepubliceerd in: (2022-10-01)

S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA
door: M. C. Pirosa, et al.
Gepubliceerd in: (2022-06-01)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
door: Arun Seshachalam, et al.
Gepubliceerd in: (2019-12-01)

P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET
Gepubliceerd in: (2018-10-01)

P1070: DECISIONAL ROLE OF INTERIM PET IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA TREATED WITH BEGEV CHEMOTHERAPY AS FIRST SALVAGE
door: Chiara Rusconi, et al.
Gepubliceerd in: (2023-08-01)

FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?
door: Josée M. Zijlstra, et al.
Gepubliceerd in: (2016-11-01)

Interim results of a UK NCRI randomised trial comparing involved field radiotherapy with no further treatment after 3 cycles ABVD and a negative PET scan in clinical stages IA/IIA Hodgkin lymphoma
door: Radford, J, et al.
Gepubliceerd in: (2007)

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma
door: Tim M. Illidge, et al.
Gepubliceerd in: (2020-01-01)

P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
door: Eleonora Calabretta, et al.
Gepubliceerd in: (2022-10-01)

P026 (0057) INTERIM- PET RESULTS FOR PROGNOSIS IN ADULTS WITH HODGKIN LYMPHOMA: A PROGNOSTIC FACTOR EXEMPLAR REVIEW (PRELIMINARY RESULTS)
Gepubliceerd in: (2018-10-01)

P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials
door: Simonetta Viviani, et al.
Gepubliceerd in: (2022-10-01)

Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report
door: Lars Kurch, et al.
Gepubliceerd in: (2022-01-01)

The role of FDG-PET in Hodgkin lymphoma
door: Edyta Subocz, et al.
Gepubliceerd in: (2017-06-01)

Healthy tissue metabolism assessed by [18F]FDG PET/CT as a marker of prognosis and adverse events in advanced Hodgkin lymphoma patients
door: Afnan A. Malaih, et al.
Gepubliceerd in: (2024-06-01)

The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria
door: Elske Quak, et al.
Gepubliceerd in: (2014-06-01)

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
door: Andrea Gallamini, et al.
Gepubliceerd in: (2014-06-01)

The utility of PET/CT with 18F-FDG in the study of Hodgkin's lymphoma and non-Hodgkin's lymphoma
door: Marta Milhões, et al.
Gepubliceerd in: (2015-11-01)

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
door: Stephen Daw, et al.
Gepubliceerd in: (2020-02-01)

T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies
door: Dennis A. Eichenauer, et al.
Gepubliceerd in: (2022-10-01)

Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group
door: Aznar, M, et al.
Gepubliceerd in: (2017)

MRI versus CT and PET/CT in the Preoperative Assessment of Hodgkin and Non-Hodgkin Lymphomas
door: Francesca Maccioni, et al.
Gepubliceerd in: (2021-10-01)

Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma
door: Özgür Ömür, et al.
Gepubliceerd in: (2014-03-01)

Machine Learning to Predict Interim Response in Pediatric Classical Hodgkin Lymphoma Using Affordable Blood Tests
door: Jennifer A. Geel, et al.
Gepubliceerd in: (2024-10-01)